Introduction
============

Esophageal squamous cell carcinoma (ESCC) is one of the six most common cancers worldwide, especially in China and other Asian countries ([@b21-gmb-35-2-530]; [@b44-gmb-35-2-530]). Despite improvements in detection, surgical techniques and chemoradiotherapy, the five-year survival rate remains low ([@b18-gmb-35-2-530]). Prediction is usually according to tumor, node and metastasis system (TNM) classification. However, TNM classification merely reflects the status of cancer progression at the time of diagnosis. In contrast, molecular biological analysis clarifies biological behavior during cancer progression. Thus, the combination of the two could be more accurate in reflecting the clinical outcome ([@b34-gmb-35-2-530]).

Recently, it was discovered that certain genes could be associated with inadequate ESCC prognosis. For example, the high expression of CCR7 ([@b11-gmb-35-2-530]), COX2 ([@b33-gmb-35-2-530]), Beclin-1 ([@b8-gmb-35-2-530]), TLR9 ([@b32-gmb-35-2-530]), and FOXC2 ([@b26-gmb-35-2-530]), could be significantly correlated with invasion, stage, tumor depth, lymph node metastasis, and poor survival. Overexpression of steroid receptor coactivatior-3(SRC-3) was more frequently observed in primary ESCC in the late T stages (T3/T4) than in the earlier T1/T2 ([@b38-gmb-35-2-530]). Although over-expression of cysteine-rich 61 (Cyr61) was related to less overall survival of patients in stage I/II, there was no affect on the overall survival of patients in stage III/IV ([@b37-gmb-35-2-530]). Low claudin-4 expression was found to be significantly associated with histological differentiation, invasion depth, and lymph node metastasis. Low claudin-4 expression revealed an unfavorable influence on disease-free and overall survival ([@b30-gmb-35-2-530]). PRL-1 protein expression significantly correlated with the stage of ESCC, 79.4% of the cases (27/34) in stage III ESCC, and 33.3% of the cases (1/3) in stage 1 ESCC ([@b40-gmb-35-2-530]).

However, additional molecular prognostic markers are essential as aids in developing more effective therapeutic strategies for better prognosis. In this study, the aim was to identify more differentially expressed genes in ESCC, and predict their underlying functions. Meta-analysis provides a powerful tool for analyzing microarray experiments by combining data from multiple studies, besides presenting unique computational challenges. The Bioconductor package RankProd provides a novel and intuitive tool for this, by detecting differentially expressed genes by means of the non-parametric rank product method ([@b14-gmb-35-2-530]). The graphclustering approach was used for identifying gene expression profiles that distinguish ESCC from normal samples. Furthermore, the relevant pathways in the cluster were also analyzed by GO term analysis, to so explain potential mechanisms in response to ESCC.

Data and Methods
================

Meta-analysis for expression profile and differentially expressed gene (DEG) analysis
-------------------------------------------------------------------------------------

Two ESCC related expression profiles, GSE23400 and GSE20347, were obtained separately from a public functional genomics data repository GEO, based on the Affymetrix Human Genome U133A Array and Affymetrix Human Genome U133A 2.0 Array, respectively.

In the GSE23400 dataset, 53 ESCC and 53 matched-normal samples were analyzed. Contributors chose not to include clinical phenotypes in their GEO submission ([@b30-gmb-35-2-530]). In the GSE20347 dataset, 17 ESCC and 17 matched-normal samples were approved by the Institutional Review Boards of the Shanxi Cancer Hospital, and the US National Cancer Institute (NCI). Cases diagnosed with ESCC between 1998 and 2001 in the Shanxi Cancer Hospital in Taiyuan, Shanxi Province, PR China, and considered candidates for curative surgical resection, were identified and recruited for participation in the study. None of the cases had undergone prior therapy. Shanxi was the ancestral home of all of them. After obtaining informed consent, cases were interviewed, as a means of obtaining information on demographics, cancer risk factors (*e.g.*, smoking, alcohol consumption, and a detailed family history of cancer), and clinical information ([@b39-gmb-35-2-530]; [@b15-gmb-35-2-530]).

Statistical analysis
--------------------

DEGs for the GSE23400 and GSE20347 dataset were first independently identified with the limma method, whereupon the RankProd package was then applied to overcome heterogeneity. Only those with a percentage of false-positives (PFP) ([@b14-gmb-35-2-530]) = 1% were considered differentially expressed between treatments and controls.

The Spearman rank correlation (r) was used for assaying comparative target-gene correlations, to thus demonstrate the potential connection between DEGs. This coefficient ([@b9-gmb-35-2-530]), which is conceptually similar to the Pearson correlation, measures the strength of the associations between two variables. The significance level was set at r \>0.9, which is a more stringent threshold than the empirical value ([@b12-gmb-35-2-530]). Detection of this level was with DPClus. All statistical tests were carried out with the R program. A detailed workflow is shown in [Figure 1](#f1-gmb-35-2-530){ref-type="fig"}.

Co-expression Network analysis and graph-clustering
---------------------------------------------------

DPClus ([@b3-gmb-35-2-530]), a graph-clustering algorithm that can extract densely connected nodes as a cluster, was used to identify co-expressed groups. It is based on the density-and-periphery tracking of clusters. In this study, the overlapping-mode with DPClus settings was used. The parameter settings of cluster property cp; density values were set to 0.5 ([@b12-gmb-35-2-530]).

GO Term enrichment analysis
---------------------------

The use of Gene Ontology (GO) terms by collaborating databases facilitates uniform queries. The controlled vocabularies are structured for queries at different levels, thereby also facilitating the assignment of properties to genes or gene products, also at different levels, depending on the depth of knowledge involved.

DAVID ([@b16-gmb-35-2-530]) was used to identify which GO terms were significantly over-represented in the biological process. The terms with p-value \<0.05 and count numbers \>2 were considered as significant ([@b5-gmb-35-2-530]; [@b13-gmb-35-2-530]).

Results
=======

Differently expressed gene selection and correlation network construction
-------------------------------------------------------------------------

The publicly available microarray data sets, GSE23400 and GSE20347, were obtained from GEO. Differentially expressed genes (DEGs) with fold change \>2 and p-value \<0.05 were selected by microarray analysis. Following limma method analysis, 519 genes from GSE23400 and 1360 from GSE20347 were selected as DEGs. On applying RankProd packages for meta-analysis, 9 up-regulated genes and 1876 down-regulated ones, with a percentage of false-positives (PFP) 1% and fold change value \>2, were considered differentially expressed. 1885 DEGs were finally collected after meta-analysis ([Figure 2](#f2-gmb-35-2-530){ref-type="fig"}).

To obtain the relationships among DEGs, the co-expressed value r = 0.9 and corrected p-value = 0.01 were considered as threshold. Finally, a correlation network was constructed from 724 relationships among 202 DEGs ([Figure 3](#f3-gmb-35-2-530){ref-type="fig"}).

Graph-clustering identifies modules significantly enriched in biochemical pathways
----------------------------------------------------------------------------------

At r \>0.9, DPClus ([@b3-gmb-35-2-530]) was used for identifying 6 clusters, ranging in size from 8 to 22 genes, in the correlation network of ESCC ([Figure 3](#f3-gmb-35-2-530){ref-type="fig"}). Clusters 1, 4, 5 and 6, in particular, have mutual connections since they share the same genes. The more genes shared, the greater mutual connectivity (corresponding to thicker lines). Graph-clustering results are presented in [Figure 4](#f4-gmb-35-2-530){ref-type="fig"}. The over-represented GO terms in the clusters were used to assess their significance. The results of graph-clustering by GO term enrichment analysis appear in [Table 1](#t1-gmb-35-2-530){ref-type="table"}.

Significant GO Terms (p-value \<0.05, using the hypergeometric test) were listed, as to fucose catabolic process, cytoskeleton organization, epidermis development, response to injury, etc. ([Table 1](#t1-gmb-35-2-530){ref-type="table"}). Ectoderm development (GO:0007398), epidermis development (GO:0008544) and epidermal cell differentiation (GO:0009913) were commonly enriched in clusters 4 and 5. Keratinization (GO:0031424) was enriched in clusters 1 and 4.

Discussion
==========

In this study, 1885 DEGs were first identified through meta-analysis. Among these, a correlation network was constructed with 202 DEGs producing 724 relationships. By applying graph-clustering, these 202 DEGs were then clustered into six clusters. Clusters 1, 4, 5 and 6 seemed to be mutually connected. Details of these connections were confirmed by GO-term enrichment analysis, whereby it was shown that the genes of cluster 1 may be involved in the fucose catabolic process, whereas those in clusters 4 and 5 were mainly associated with epidermis development and differentiation. Although there was no connection between cluster 2 and the others, it was also significantly effective in ESCC invasion and metastasis. The genes in this cluster were related to cytoskeleton and extracellular matrix organization. Therefore, the proposal is to speculate on certain genes in these clusters, identifiably involved in ESCC.

Cluster 2: CXCL12
-----------------

CXCL12, also known as stromal cell-derived factor-1, was first discovered among the chemokines secreted by mouse bone-marrow stromal cells, with CXCR4 as its specific receptor. The two interact to form a coupled molecular pair, which plays a prominent role in regulating directional migration and proliferation in ESCC, where both are positively located within the membrane and cytoplasm ([@b35-gmb-35-2-530]). Expression of the two is significantly correlated with lymph node metastasis, in the tumor stage, gender and lymphatic invasion. The overall and disease-free survival rate is significantly lower in patients with positive CXCL12 expression than in those with negative ([@b28-gmb-35-2-530]). Furthermore, the CXCL12-CXCR4 combination possibly induces up-regulated expression of matrix metalloproteinases, whereby their further involvement in extracellular matrix modeling and the mediation of metastasis in ESCC, ([@b41-gmb-35-2-530]; [@b4-gmb-35-2-530]; [@b23-gmb-35-2-530]). Apparently, MMP-7, MMP-9, and MT1-MMP are also closely associated with invasion depth and venous invasion in ESCC ([@b27-gmb-35-2-530]). This predicted mechanism was in accordance with our GO-term analysis.

Cluster 3: CYP2C9
-----------------

In ESCC, higher CYP2C9 expression levels occur in the early tumor stages (pT1/pT2), compared to more advanced local tumors (pT3/pT4). Its selective inhibition decreases tumor-cell proliferation and G0/G1 phase cell-cycle arrest ([@b29-gmb-35-2-530]). Although, even with GO-term analysis, the role of these genes in cluster 3 remained unknown, the inference is their possible involvement in the tumor-cell cycle, in accordance with their function.

Cluster 4: TGM3 and MAL genes
-----------------------------

TGM3 is a member of a family of Ca^2+^-dependent enzymes, thought to be critically involved in the cross-linking of structural proteins and formation of the cell envelope (CE), thereby contributing to the rigid structures that play vital roles in shape determination and barrier functions. The down-regulation of TGM3 genes in human ESCC tissues may lead to incapacity to form CEs and sustain toxic material (Chen *et al.* 2000; [@b24-gmb-35-2-530]). Although TGM3 expression is significantly inversely correlated with the histological grade of esophageal carcinoma, there is no obvious correlation with lymph node metastasis and depth of invasion. So, there is every indication that this gene may be an important adhesion molecule expressed by epithelial cells, and thus regarded as an invasion suppressor molecule in ESCC ([@b22-gmb-35-2-530]). Although details of its role in ESCC were not clear, it is proposed that it may be involved in esophageal epithelial cell differentiation and keratinocyte differentiation, as previous described ([@b42-gmb-35-2-530]). The MAL gene, a T-cell differentiation antigen, was found to be down-regulated in 10 ESCC-patients bearing tumors in different stages of development ([@b19-gmb-35-2-530]). It has already been shown to express in four alternatively spliced forms of transcripts during the intermediate and late stages of T-cell differentiation, and in that of epithelial cells ([@b2-gmb-35-2-530]). Its ectopic expression in carcinoma TE3 cells could lead to the repressed formation of tumors in nude mice, the inhibition of cell motility, and the production of apoptosis by the Fas pathway ([@b25-gmb-35-2-530]), whereby the proposal that Mal may be a tumor suppressor gene in ESCC development.

Cluster 5: S100A9 gene
----------------------

S100A9, a calcium-binding protein belonging to the S100 family, was detected as significantly down-regulated in ESCC ([@b17-gmb-35-2-530]). Moreover, S100A9 staining is decreased in poorly and moderately differentiated ESCCs, when compared with those well-differentiated, hence the inferrence that loss of S100A9 expression in ESCC generally occurs along with worsening esophageal epithelial differentiation in histological grades ([@b20-gmb-35-2-530]). These genes, together with the other 11 S100 genes and epidermal differentiation complex (EDC) genes, have been mapped to human chromosome 1q21, which is a region of structural and numerical aberration, involved in esophageal carcinogenesis and progression ([@b24-gmb-35-2-530]). In brief, down-regulation of S100A9 is a common event in esophageal carcinogenesis and progression through affecting epithelial cell differentiation, proliferation and apoptosis, as well as the expression of genes encoding epidermal structural proteins in a calcium-dependent manner (Luo *et al.* 2003; [@b44-gmb-35-2-530]; [@b45-gmb-35-2-530]).

Common genes in clusters 4 and 5: EMP-1 and SPRR3
-------------------------------------------------

Clusters 4 and 5 were closely connected by several genes ([Figure 4](#f4-gmb-35-2-530){ref-type="fig"}), such as EMP-1 and SPRR3. The expression of EMP-1, a member of the PMP22 family, is found to be down-regulated in esophageal cancers ([@b46-gmb-35-2-530]). Over-expression of this gene in the EC9706 cell-line leads to inhibited cell proliferation, S-phase arrest, and G1-phase prolongation, thus indicating its participation in the cell-cycle. In addition, EMP-1 transfection could induce different forms of gene expression, such as integrin beta 7 (ITGB7), integrin beta 8 (ITGB8) and cadherin 5 (CDH5), involved in cell signaling, cell adhesion and cell-cell communication. Retinoic acid receptor beta (RAR-β) is another up-regulated gene induced by EMP-1. Retinoids can modulate epithelial cell-growth, differentiation, and apoptosis *in vitro* and *in vivo* by binding to specific nuclear retinoid receptors, such as RAR-β. They can also prevent abnormal squamous cell differentiation in non-keratinizing tissues. Therefore, the EMP-1 and RAR-β interaction might also play important roles in epithelial cell and keratinocyte differentiation ([@b36-gmb-35-2-530]).

SPRR3, one of the substrates for TGM3, is a small proline-rich protein, abundantly expressed in oral and esophageal epithelia. Its expression, although less concomitant with TGM3 loss in ESCC ([@b24-gmb-35-2-530]), is highly induced during human epidermal keratinocyte differentiation, thus being considered a differentiation marker of squamous epithelium ([@b1-gmb-35-2-530]). Recent reviews imply that SPRR3 is frequently down-regulated in ESCC, when compared to adjacent paired mucosa ([@b6-gmb-35-2-530]; [@b10-gmb-35-2-530]). Further studies have shown that exogenous expression of SPRR3 significantly suppresses ESCC cell formation by inducing CDK11p46 protein expression and apoptosis ([@b43-gmb-35-2-530]). Therefore, SPRR3 might play a crucial role in the maintenance of normal esophageal epithelial homeostasis.

Finally, the combination meta-analysis, graph-clustering and GO term analysis is presumedly effective for identifying differentially expressed genes, and speculating on their respective roles in ESCC. Hence, other unidentified genes will be the focus of our future studies.

![Workflow of our study. The RankProd package was used for merging the GSE23400 and GSE20347 datasets, as was the Spearman Rank Correlation for constructing a co-expression network based on their expression profiles. The Graph-clustering approach was applied for identifying enriched clusters. Finally, the function annotation of each cluster was found through GO-Term enrichment analysis.](gmb-35-2-530-gfig1){#f1-gmb-35-2-530}

![Differentially expressed genes (DEGs) in gse23400, gse20347 and meta-datasets. The Venn diagram shows significant genes in ESCC.](gmb-35-2-530-gfig2){#f2-gmb-35-2-530}

![Correlation network of ESCC. Yellow dots indicate DEGs and blue lines the correlation of two neighboring points, with r \> 0.9.](gmb-35-2-530-gfig3){#f3-gmb-35-2-530}

![Graph-clustering of correlated modules in ESCC (threshold r = 0.9). Red lines mean connections with other clusters containing the same genes, and green lines connections within the current cluster, without outside connections.](gmb-35-2-530-gfig4){#f4-gmb-35-2-530}

###### 

List of enriched GO terms in clusters 1 to 6 detected by DPClus.

  Category     GO Term                                   Description                 P-value    FDR
  ------------ ----------------------------------------- --------------------------- ---------- ----------
  Cluster1     GO:0019317                                fucose catabolic process    0.010304   0.598071
  GO:0042355   L-fucose catabolic process                0.010304                    0.598071   
  GO:0042354   L-fucose metabolic process                0.012353                    0.421275   
  GO:0006004   fucose metabolic process                  0.018477                    0.421345   
  GO:0031424   keratinization                            0.043613                    0.625078   
                                                                                                
  Cluster2     GO:0007010                                cytoskeleton organization   2.06E-04   0.063509
  GO:0030198   extracellular matrix organization         3.31E-04                    0.051459   
  GO:0043062   extracellular structure organization      0.001227                    0.122371   
  GO:0030036   actin cytoskeleton organization           0.003119                    0.22052    
  GO:0030029   actin filament-based process              0.003738                    0.212548   
  GO:0048251   elastic fiber assembly                    0.005312                    0.246622   
  GO:0007155   cell adhesion                             0.012164                    0.427484   
  GO:0022610   biological adhesion                       0.012223                    0.38762    
  GO:0006875   cellular metal ion homeostasis            0.027439                    0.626993   
  GO:0055065   metal ion homeostasis                     0.029813                    0.61921    
  GO:0007044   cell-substrate junction assembly          0.030184                    0.588854   
  GO:0031032   actomyosin structure organization         0.03663                     0.629181   
  GO:0030199   collagen fibril organization              0.037915                    0.612667   
  GO:0030003   cellular cation homeostasis               0.044093                    0.642105   
  GO:0006940   regulation of smooth muscle contraction   0.049403                    0.659545   
                                                                                                
  Cluster3                                                                                      
                                                                                                
  Cluster4     GO:0008544                                epidermis development       1.91E-07   2.65E-05
  GO:0007398   ectoderm development                      2.82E-07                    1.96E-05   
  GO:0030855   epithelial cell differentiation           3.14E-06                    1.46E-04   
  GO:0009913   epidermal cell differentiation            2.31E-05                    8.04E-04   
  GO:0060429   epithelium development                    2.32E-05                    6.46E-04   
  GO:0030216   keratinocyte differentiation              0.001253                    0.028635   
  GO:0022405   hair cycle process                        0.033638                    0.493107   
  GO:0022404   molting cycle process                     0.033638                    0.493107   
  GO:0001942   hair follicle development                 0.033638                    0.493107   
  GO:0042633   hair cycle                                0.034427                    0.455943   
  GO:0031424   keratinization                            0.034427                    0.455943   
  GO:0042303   molting cycle                             0.034427                    0.455943   
                                                                                                
  Cluster5     GO:0009611                                response to wounding        0.00186    0.476806
  GO:0030855   epithelial cell differentiation           0.002068                    0.302477   
  GO:0008544   epidermis development                     0.003694                    0.349054   
  GO:0007398   ectoderm development                      0.004307                    0.313061   
  GO:0060429   epithelium development                    0.005569                    0.322047   
  GO:0006954   inflammatory response                     0.011156                    0.478307   
  GO:0006928   cell motion                               0.022979                    0.685173   
  GO:0050900   leukocyte migration                       0.029131                    0.723626   
  GO:0030216   keratinocyte differentiation              0.033663                    0.733943   
  GO:0009913   epidermal cell differentiation            0.036674                    0.72754    
  GO:0006952   defense response                          0.037216                    0.698761   
                                                                                                
  Cluster6                                                                                      
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